Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 28, 2014 08:09 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Appoints Donald D. Huffman to Board of Directors

SAN FRANCISCO and GENEVA, July 28, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and...
July 23, 2014 11:34 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus and BSI Announce Dr. Thomas Arendt as Presenter at 3rd Alzheimer's Focused #C4CT Concussion Awareness Summit at United Nations

NEW YORK and SAN FRANCISCO, July 23, 2014 (GLOBE NEWSWIRE) -- Brewer Sports International (BSI), a multi-faceted global sports advisory firm, and Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a...
July 22, 2014 15:47 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus and BSI Proudly Announce BIO CEO & President Jim Greenwood as Panelist for 3rd Alzheimer's Focused #C4CT Concussion Awareness Summit at United Nations

MINNEAPOLIS and NEW YORK, July 22, 2014 (GLOBE NEWSWIRE) -- Brewer Sports International (BSI), a multi-faceted global sports advisory firm, and Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a...
July 18, 2014 07:49 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Discusses New Independent Peer-Reviewed Research Papers on MANF

SAN FRANCISCO and GENEVA, July 18, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and...
July 17, 2014 08:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus and BSI Announce Continued Support of One Mind at the 3rd #C4CT Concussion Awareness Summit at the United Nations

MINNEAPOLIS, SAN FRANCISCO and GENEVA, July 17, 2014 (GLOBE NEWSWIRE) -- Brewer Sports International (BSI), a multi-faceted global sports advisory firm, and Amarantus Bioscience Holdings, Inc....
July 15, 2014 09:27 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Announces Positive Clinical Performance and 7-Year Longitudinal Data Poster Presentations for LymPro Test (R) at AAIC 2014

SAN FRANCISCO and GENEVA, July 15, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and...
July 14, 2014 08:58 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Announces Positive Analytical Performance Data Poster Presentation for LymPro Test (R) at AAIC 2014

SAN FRANCISCO and GENEVA, July 14, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and...
July 07, 2014 16:25 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus' CEO to Host Twitter Chat on Thursday, July 10, 2014 at 4pm EDT

SAN FRANCISCO, July 7, 2014 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, Inc. (OTCBB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics...
July 07, 2014 08:30 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Announces Three Data Presentations Related to the Company's LymPro Diagnostic Test at the Alzheimer's Association International Conference (AAIC)

SAN FRANCISCO and GENEVA, July 7, 2014 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and...
July 02, 2014 09:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Announces Positive Interim Toxicology Data for MANF in Retinitis Pigmentosa

SAN FRANCISCO and GENEVA, July 2, 2014 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and...